Prospective Evaluation of Rate of Hindfoot/Ankle Fusion with Augment Injectable Bone Graft

Prospective Evaluation of Rate of Hindfoot/Ankle Fusion with Augment Injectable Bone Graft

Category: Hindfoot; Ankle Introduction/Purpose: Augment ® Bone Graft is a mixture of rhPDGF-BB, beta-TCP and bovine collagen which has received FDA approval for use as a substitute for autografts during hindfoot and/or ankle arthrodesis. Although a recent meta analysis demonstrated that the rhPDGF-B...

Full description

Saved in:
Bibliographic Details
Main Authors: Jacob Priester MD, Christopher D. Kreulen MD, Phillip J. Shaheen MD, Eric Giza MD, Samuel Simister MD
Format: Article
Language:English
Published: SAGE Publishing 2024-12-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/2473011424S00452
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items